Navigation Links
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
Date:9/18/2009

A federal jury in Tampa Florida returned a verdict in favor of Hako-Med finding that Axiom Worldwide willfully infringed Hako-Med's Horizontal Therapy patent and awarded damages(United States District Court, Middle District of Florida Case No.: 8:06-cv1790-T33AEP). In addition, the federal court issued another permanent injunction against Axiom Worldwide barring all EPS 8000 devices manufactured prior to November 28th 2006.

Honolulu, HI (PRWEB) September 18, 2009 -- A federal jury in Tampa Florida returned a verdict in favor of Hako-Med finding that Axiom Worldwide willfully infringed Hako-Med's Horizontal Therapy patent and awarded damages (United States District Court, Middle District of Florida Case No.: 8:06-cv1790-T33AEP). In addition, the federal court issued another permanent injunction against Axiom Worldwide barring all EPS 8000 devices manufactured prior to November 28th 2006.

A day earlier a federal judge in the United States District Court, Middle District of Florida, Tampa division, the honorable Virginia M. Hernandez Covington, made a temporary injunction against Axiom Worldwide permanent thereby baring Axiom Worldwide from using one of Hako-Med's trademarks.

Axiom Worldwide, based in Tampa Florida, manufactures spinal decompression devices as well as a pain management device, which was found to infringe on Hako-Med's unique patented pain therapy. Axiom Worldwide's head-engineer further admitted under oath that Axiom had done no validation through published clinical studies on their EPS 8000 devices prior to marketing the unsubstantiated claims to physicians that the EPS8000 devices "presents a breakthrough in electrical stimulation therapy" and "the most advanced Electrical Nerve stimulation available today."

Axiom Worldwide has additional pending litigation with other companies, including an alleged trademark infringement suit. (North American Medical vs. Axiom Worldwide No. 1:06-CV-1678-JTC)

Hako-Med offers a special amnesty period from civil litigations for any physician who wants to upgrade from an infringing device to Hako-Med Horizontal Therapy devices by the end of October 2009. (www.hakomed.com)

Hako-Med's policy is to vigorously defend its intellectual property portfolio. Hako-Med is the only manufacturer and supplier of devices with the patented Horizontal Therapy. Horizontal Therapy has been known through many clinical trials to outperform existing treatment methods in the treatment of pain from Osteoarthritis by having immediate as well as longer lasting therapeutic effects without any negative side effects.

For interviews please contact. Kai Hansjurgens president of Hako-Med USA at 1-888-913-7900 www.hakomed.com.

###

Read the full story at http://www.prweb.com/releases/Horizontal_Therapy/Patent_Infringement/prweb2905684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. AXIOM Selects Foresight Corp. for Integration Partnership
2. Axiom Named to Healthcare Informatics Top 100 List
3. Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
4. Global Decompression Announces C.O.D. Available on All Used Axiom DRX 9000 Spinal Decompression Systems
5. WorldatWork Publishes Axiom Consulting Partners' Article on ‘Planning for the New Normal', an Alternative Approach to Compensation Planning
6. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
7. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
8. Global Med Technologies(R) Extends Its Worldwide Outreach
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
11. New USAID grant helps Georgetown meet unmet family planning needs worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
(Date:5/3/2016)... NY (PRWEB) , ... May 04, 2016 , ... ... a 2016-2017 inductee into its VIP Woman of the Year Circle. She is recognized ... organization exclusively for professional women, boasting more than 850,000 members and over 200 operating ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of NCPDP and member ... Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the National Coordinator for ...
(Date:5/3/2016)... ... 2016 , ... California health startup Pegara announced today the ... assess their risk of developing Alzheimer’s disease. Using a questionnaire based on years ... Score™” that summarizes how their lifestyle choices may affect their chances of developing ...
(Date:5/3/2016)... CA (PRWEB) , ... May 03, 2016 , ... ... is a process that selects DNA or RNA from a random library of ... potentially be used as drugs or diagnostic agents. SELEX selection is commonly performed ...
(Date:5/3/2016)... Fla. (PRWEB) , ... May 03, 2016 , ... Elizabeth ... her pet parrots to join her with one on her shoulder and one on ... through a parking lot because of years of mitral valve prolapse. , The valves ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016 ReportsnReports.com ... 2016" market research report that provides an overview ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:4/29/2016)... April 29, 2016 Automation is ... laboratory due to the growing demands for productivity in ... contemporary automated systems are already adept of a wide ... tedious and manual labor. Instrumentation continues to evolve, and ... conceivable just a few years ago. Originally used mostly ...
(Date:4/28/2016)... BURLINGAME, Calif. , April 28, 2016 /PRNewswire/ ... first-ever widely accessible breast and ovarian cancer risk ... cancer panel analyzing 30 genes that highly impact ... and women. Available today, the Color Test analyzes ... pancreatic, prostate, stomach, and uterine cancers. The Color ...
Breaking Medicine Technology: